3
Kimura Disease Followup Author: Evan W Piette, MD; Chief Editor: William D James, MD more... Updated: Mar 20, 2014 Complications Rarely, large nodules or tumors from Kimura disease have ulcerated. After treatment, recurrence also has been reported. Abbas et al reported one case of postsurgical facial disfigurement effectively treated with photodynamic therapy. [28] Prognosis The course of Kimura disease is chronic, with lesions frequently persisting or recurring despite treatment. To date, malignant transformation of Kimura disease has not been described in the literature. If not treated, Kimura disease can lead to disfigurement. Contributor Information and Disclosures Author Evan W Piette, MD Resident Physician, Department of Dermatology, Hospital of the University of Pennsylvania Evan W Piette, MD is a member of the following medical societies: American Academy of Dermatology Disclosure: Nothing to disclose. Coauthor(s) Alaina J James, MD, PhD Assistant Professor, Department of Dermatology, The Hospital of the University of Pennsylvania Alaina J James, MD, PhD is a member of the following medical societies: American Academy of Dermatology, National Medical Association, and Women's Dermatologic Society Disclosure: Nothing to disclose. Specialty Editor Board Takeji Nishikawa, MD Emeritus Professor, Department of Dermatology, Keio University School of Medicine; Director, Samoncho Dermatology Clinic; Managing Director, The Waksman Foundation of Japan Inc Disclosure: Nothing to disclose. Michael J Wells, MD Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association Disclosure: Nothing to disclose. Daniel S Loo, MD Associate Professor of Dermatology, Residency Program Director, Department of Dermatology, Tufts Medical Center Daniel S Loo, MD is a member of the following medical societies: American Academy of Dermatology and Association of Professors of Dermatology Disclosure: Nothing to disclose. Joel M Gelfand, MD, MSCE Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds Investigator; Genentech Grant/research funds investigator; Centocor Consulting fee Consulting; Abbott Grant/research funds investigator; Abbott Consulting fee Consulting; Novartis investigator; Pfizer Grant/research funds investigator; Celgene Consulting fee DMC Chair; NIAMS and NHLBI Grant/research funds investigator Chief Editor William D James, MD Paul R Gross Professor of Dermatology, ViceChairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology Disclosure: Nothing to disclose.

Kimura Disease Follow-up

Embed Size (px)

DESCRIPTION

kimura

Citation preview

  • 4/28/2015 KimuraDiseaseFollowup

    http://emedicine.medscape.com/article/1098777followup#showall 1/3

    KimuraDiseaseFollowupAuthor:EvanWPiette,MDChiefEditor:WilliamDJames,MDmore...

    Updated:Mar20,2014

    ComplicationsRarely,largenodulesortumorsfromKimuradiseasehaveulcerated.Aftertreatment,recurrencealsohasbeenreported.

    Abbasetalreportedonecaseofpostsurgicalfacialdisfigurementeffectivelytreatedwithphotodynamictherapy.[28]

    PrognosisThecourseofKimuradiseaseischronic,withlesionsfrequentlypersistingorrecurringdespitetreatment.

    Todate,malignanttransformationofKimuradiseasehasnotbeendescribedintheliterature.

    Ifnottreated,Kimuradiseasecanleadtodisfigurement.

    ContributorInformationandDisclosuresAuthorEvanWPiette,MDResidentPhysician,DepartmentofDermatology,HospitaloftheUniversityofPennsylvania

    EvanWPiette,MDisamemberofthefollowingmedicalsocieties:AmericanAcademyofDermatology

    Disclosure:Nothingtodisclose.

    Coauthor(s)AlainaJJames,MD,PhDAssistantProfessor,DepartmentofDermatology,TheHospitaloftheUniversityofPennsylvania

    AlainaJJames,MD,PhDisamemberofthefollowingmedicalsocieties:AmericanAcademyofDermatology,NationalMedicalAssociation,andWomen'sDermatologicSociety

    Disclosure:Nothingtodisclose.

    SpecialtyEditorBoardTakejiNishikawa,MDEmeritusProfessor,DepartmentofDermatology,KeioUniversitySchoolofMedicineDirector,SamonchoDermatologyClinicManagingDirector,TheWaksmanFoundationofJapanInc

    Disclosure:Nothingtodisclose.

    MichaelJWells,MDAssociateProfessor,DepartmentofDermatology,TexasTechUniversityHealthSciencesCenter,PaulLFosterSchoolofMedicine

    MichaelJWells,MDisamemberofthefollowingmedicalsocieties:AlphaOmegaAlpha,AmericanAcademyofDermatology,AmericanMedicalAssociation,andTexasMedicalAssociation

    Disclosure:Nothingtodisclose.

    DanielSLoo,MDAssociateProfessorofDermatology,ResidencyProgramDirector,DepartmentofDermatology,TuftsMedicalCenter

    DanielSLoo,MDisamemberofthefollowingmedicalsocieties:AmericanAcademyofDermatologyandAssociationofProfessorsofDermatology

    Disclosure:Nothingtodisclose.

    JoelMGelfand,MD,MSCEMedicalDirector,ClinicalStudiesUnit,AssistantProfessor,DepartmentofDermatology,AssociateScholar,CenterforClinicalEpidemiologyandBiostatistics,UniversityofPennsylvania

    JoelMGelfand,MD,MSCEisamemberofthefollowingmedicalsocieties:SocietyforInvestigativeDermatology

    Disclosure:AMGENConsultingfeeConsultingAMGENGrant/researchfundsInvestigatorGenentechGrant/researchfundsinvestigatorCentocorConsultingfeeConsultingAbbottGrant/researchfundsinvestigatorAbbottConsultingfeeConsultingNovartisinvestigatorPfizerGrant/researchfundsinvestigatorCelgeneConsultingfeeDMCChairNIAMSandNHLBIGrant/researchfundsinvestigator

    ChiefEditorWilliamDJames,MDPaulRGrossProfessorofDermatology,ViceChairman,ResidencyProgramDirector,DepartmentofDermatology,UniversityofPennsylvaniaSchoolofMedicine

    WilliamDJames,MDisamemberofthefollowingmedicalsocieties:AmericanAcademyofDermatologyandSocietyforInvestigativeDermatology

    Disclosure:Nothingtodisclose.

  • 4/28/2015 KimuraDiseaseFollowup

    http://emedicine.medscape.com/article/1098777followup#showall 2/3

    AdditionalContributorsSenaJLee,MD,PhDResidentPhysician,DepartmentofDermatology,HospitalofUniversityofPennsylvania

    Disclosure:Nothingtodisclose.

    PatriciaMercado,MDAssociateProfessorofDermatology,UniversityofAlabamaatBirminghamSchoolofMedicine

    Disclosure:Nothingtodisclose.

    LauraMTamburin,MDAffiliatedDermatology,PC

    Disclosure:Nothingtodisclose.

    KarolynAWanat,MDResidentPhysician,DepartmentofDermatology,UniversityofPennsylvaniaSchoolofMedicine

    KarolynAWanat,MDisamemberofthefollowingmedicalsocieties:AlphaOmegaAlpha,AmericanAcademyofDermatology,AmericanMedicalAssociation,andAmericanMedicalWomen'sAssociation

    Disclosure:Nothingtodisclose.

    References

    1. KimmHT,SzetoC.Eosinophilichyperplasticlymphogranuloma,comparisonwithMikulicz'sdisease.ProcChinMedSoc.1937329.

    2. KimuraT,YoshimuraS,IshikawaE.Ontheunusualgranulationcombinedwithhyperplasticchangesoflymphatictissues.TransSocPatholJpn.194837:17980.

    3. RamchandaniPL,SabesanT,HusseinK.AngiolymphoidhyperplasiawitheosinophiliamasqueradingasKimuradisease.BrJOralMaxillofacSurg.Jun200543(3):24952.[Medline].

    4. OhtaN,FukaseS,SuzukiY,ItoT,YoshitakeH,AoyagiM.IncreaseofTh2andTc1cellsinpatientswithKimura'sdisease.AurisNasusLarynx.Feb201138(1):7782.[Medline].

    5. KatagiriK,ItamiS,HatanoY,YamaguchiT,TakayasuS.InvivoexpressionofIL4,IL5,IL13andIFNgammamRNAsinperipheralbloodmononuclearcellsandeffectofcyclosporinAinapatientwithKimura'sdisease.BrJDermatol.Dec1997137(6):9727.[Medline].

    6. HosokiK,HirayamaM,KephartGM,etal.Elevatednumbersofcellsproducinginterleukin5andinterleukin10inaboywithKimuradisease.IntArchAllergyImmunol.2012158Suppl1:704.[Medline].

    7. SunQF,XuDZ,PanSH,etal.Kimuradisease:reviewoftheliterature.InternMedJ.Aug200838(8):66872.[Medline].

    8. KungIT,GibsonJB,BannatynePM.Kimura'sdisease:aclinicopathologicalstudyof21casesanditsdistinctionfromangiolymphoidhyperplasiawitheosinophilia.Pathology.Jan198416(1):3944.[Medline].

    9. WangDY,MaoJH,ZhangY,etal.Kimuradisease:acasereportandreviewoftheChineseliterature.NephronClinPract.2009111(1):c5561.[Medline].

    10. ThomasJ,JayachandranNV,ChandrasekharaPK,RajasekharL,NarsimuluG.Kimura'sdiseaseanunusualcauseoflymphadenopathyinchildren.ClinRheumatol.May200827(5):6757.[Medline].

    11. ChenH,ThompsonLD,AguileraNS,AbbondanzoSL.Kimuradisease:aclinicopathologicstudyof21cases.AmJSurgPathol.Apr200428(4):50513.[Medline].

    12. RajpootDK,PahlM,ClarkJ.NephroticsyndromeassociatedwithKimuradisease.PediatrNephrol.Jun200014(6):4868.[Medline].

    13. JenniferLeeandYeonSikHong.KimuraDiseasecomplicatedwithbowelinfarctionandmultiplearterialthrombosesintheextremities.JClinRheumatol.Jan201420:3841.

    14. YoganathanP,MeyerDR,FarberMG.BilaterallacrimalglandinvolvementwithKimuradiseaseinanAfricanAmericanmale.ArchOphthalmol.Jun2004122(6):9179.[Medline].

    15. ParkSW,KimHJ,SungKJ,LeeJH,ParkIS.Kimuradisease:CTandMRimagingfindings.AJNRAmJNeuroradiol.Apr201233(4):7848.[Medline].

    16. BonfilsP,MoyaPlanaA,BadoualC,NadriS,MalinvaudD,LaccourreyeO.IntraparotidKimuradisease.EurAnnOtorhinolaryngolHeadNeckDis.Apr2013130(2):879.[Medline].

    17. YadlaM,SriramnaveenP,SivakumarV,SandeepReddyY,SridharAV,KrishnaKishoreC.EpitrochlearmassinapatientonmaintenancehemodialysisKimuradisease.HemodialInt.Jan262012[Medline].

    18. LiD,LiYJ,ZhanFH,DangCJ.ThefalsepositivefindingofleftpulmonaryKimuradiseaseon18FFDGPET/CT.ClinNuclMed.Jul201338(7):56972.[Medline].

    19. SakamotoM,KomuraA,NishimuraS.HematoserologicalanalysisofKimura'sdiseaseforoptimaltreatment.OtolaryngolHeadNeckSurg.Jan2005132(1):15960.[Medline].

    20. OhtaN,OkazakiS,FukaseS,AkatsukaN,AoyagiM,YamakawaM.SerumconcentrationsofeosinophilcationicproteinandeosinophilsofpatientswithKimura'sdisease.AllergolInt.Mar200756(1):459.[Medline].

    21. DargentJL,VannuffelP,SaintRemyJM,FisogniS,FacchettiF.PlasmacytoiddendriticcellsinKimuradisease.AmJDermatopathol.Dec200931(8):8546.[Medline].

    22. BirolA,BozdoganO,KelesH,etal.Kimura'sdiseaseinaCaucasianmaletreatedwithcyclosporine.IntJDermatol.Dec200544(12):105960.[Medline].

  • 4/28/2015 KimuraDiseaseFollowup

    http://emedicine.medscape.com/article/1098777followup#showall 3/3

    MedscapeReference2011WebMD,LLC

    23. WangYS,TayYK,TanE,PohWT.TreatmentofKimura'sdiseasewithcyclosporine.JDermatologTreat.200516(4):2424.[Medline].

    24. KanekoK,AokiM,HattoriS,SatoM,KawanaS.SuccessfultreatmentofKimura'sdiseasewithcyclosporine.JAmAcadDermatol.Nov199941(5Pt2):8934.[Medline].

    25. HernandezBautistaV,YamazakiNakashimadaMA,VazquezGarciaR,StamatelosAlbarranD,CarrascoDazaD,RodriguezLozanoAL.TreatmentofKimuradiseasewithintravenousimmunoglobulin.Pediatrics.Dec2011128(6):e16335.[Medline].

    26. HongcharuW,BaldassanoM,TaylorCR.Kimura'sdiseasewithoralulcers:responsetopentoxifylline.JAmAcadDermatol.Nov200043(5Pt2):9057.[Medline].

    27. BoulangerE,GachotB,VerkarreV,ValensiF,BrousseN,HermineO.alltransRetinoicacidinthetreatmentofKimura'sdisease.AmJHematol.Sep200271(1):66.[Medline].

    28. AbbasS,JerjesW,UpileT,VincentA,HopperC.TreatmentofKimuradiseasewithphotodynamictherapy:acasestudy.PhotodiagnosisPhotodynTher.Mar20129(1):836.[Medline].

    29. HareyamaM,OouchiA,NagakuraH,etal.RadiotherapyforKimura'sdisease:theoptimumdosage.IntJRadiatOncolBiolPhys.Feb1199840(3):64751.[Medline].

    30. ChangAR,KimK,KimHJ,KimIH,ParkCI,JunYK.OutcomesofKimura'sdiseaseafterradiotherapyornonradiotherapeutictreatmentmodalities.IntJRadiatOncolBiolPhys.Jul15200665(4):12339.[Medline].

    31. KapoorNS,O'NeillJP,KatabiN,WongRJ,ShahJP.Kimuradisease:diagnosticchallengesandclinicalmanagement.AmJOtolaryngol.Mar201233(2):25962.[Medline].